Curaleaf Holdings (CURLF) Current Assets (2019 - 2025)

Curaleaf Holdings (CURLF) posted quarterly Current Assets of $448.6 million for Q4 2025, up 3.28% year-on-year from $434.4 million in Q4 2024, and up 3.28% on a QoQ basis from $434.4 million in Q4 2024.

Curaleaf Holdings (CURLF) Current Assets (2019 - 2025) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Current Assets for 7 consecutive years, with $448.6 million the latest figure, recorded in Q4 2025.

  • Quarterly Current Assets rose 3.28% year-over-year to $448.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $448.6 million (up 3.28% YoY) and the FY2025 annual result came in at $448.6 million, up 3.28% from the prior year.
  • Current Assets advanced to $448.6 million in Q4 2025 per CURLF's latest filing, from $434.4 million in the prior quarter.
  • Over the last five years, Current Assets for CURLF reached as high as $978.0 billion in Q1 2022 and fell as low as $418.6 million in Q4 2023.
  • A 5-year average of $65.8 billion and a median of $652.4 million in 2022 frame the typical range for Current Assets.
  • Annual changes were most pronounced in 2022 — Current Assets soared 135828.6% — and 2023, when it tumbled 50.36%.
  • Year by year, Current Assets stood at $726.6 million in 2021, then declined by 10.21% to $652.4 million in 2022, then slumped by 35.84% to $418.6 million in 2023, then advanced by 3.77% to $434.4 million in 2024, then gained by 3.28% to $448.6 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods registered $448.6 million, $434.4 million, and $422.2 million for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.05 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.71 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 6.47 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 19.71 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 2.87 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 53.60 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 10.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.44 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 3.58 Bn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 448.62 Mn
Dec 31, 2024 434.37 Mn
Sep 30, 2024 422.22 Mn
Jun 30, 2024 426.73 Mn
Dec 31, 2023 418.60 Mn
Sep 30, 2023 483.79 Mn
Jun 30, 2023 463.43 Mn
Dec 31, 2022 652.43 Mn
Sep 30, 2022 920.77 Mn
Jun 30, 2022 933.63 Mn
Mar 31, 2022 977.98 Bn
Dec 31, 2021 726.62 Mn
Sep 30, 2021 906.51 Mn
Jun 30, 2021 805.53 Mn
Mar 31, 2021 719.48 Mn
Dec 31, 2020 417.86 Mn
Sep 30, 2020 376.87 Mn
Dec 31, 2019 149.53 Mn